PIERIS PHARMACEUTICALS INC (PIRS)
US7207952026 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.54M | -33.28M | -45.74M | -37.23M | -25.47M | |||
| Depreciation Amortization | 1.90M | 2.77M | 2.46M | 2.31M | 630.00K | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 160.00K | 0.00 | |||
| Change In Working Capital | -48.14M | -33.37M | 30.53M | -16.38M | -32.12M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 16.96M | 3.95M | 5.09M | 5.24M | 4.49M | |||
| OPERATING CASH FLOW | -53.82M | -59.93M | -7.66M | -45.90M | -52.47M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -171.00K | -1.04M | -950.00K | -2.73M | -2.46M | |||
| Other Investing Activity | 12.17M | -20.20M | 0.00 | 41.94M | 12.30M | |||
| INVESTING CASH FLOW | 12.00M | -21.24M | -950.00K | 39.21M | 9.84M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 19.73M | 7.02M | 58.96M | 9.92M | 31.80M | |||
| Other Financing Activity | 66.00K | 200.00K | 170.00K | 200.00K | 370.00K | |||
| FINANCING CASH FLOW | 19.80M | 7.21M | 59.13M | 10.12M | 32.17M | |||
| Exchange Rate Effect | 783.00K | -5.18M | -3.19M | 4.75M | -2.14M | |||
| CHANGE IN CASH | -21.24M | -79.14M | 47.33M | 8.18M | -12.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.82M | -59.93M | -7.66M | -45.90M | -52.47M | |||
| Capital Expenditure | -171.00K | -1.04M | -950.00K | -2.73M | -2.46M | |||
| FREE CASH FLOW | -53.99M | -60.97M | -8.61M | -48.63M | -54.93M | |||
All data in USD